The World Patient Safety Congress Americas 2026 (formerly the World Drug Safety Congress Americas) runs 13-15 October 2026 at the Thomas M. Menino Convention & Exhibition Center in Boston, MA, USA. Organised by Terrapinn, it is billed as the #1 patient safety event in the Americas, under the theme 'Risk Management - AI & Automation - Safety Vigilance: Where Drug Safety Strategy and Technology Converge'.
The congress expects 1,200+ attendees, 250+ speakers, 100+ exhibitors, 6 tracks and 3 days. Pre-congress workshops run on 13 October (1:00pm-5:00pm), with the main congress on 14-15 October. Confirmed speakers include Mariette Boerstoel-Streefland (SVP, Worldwide Patient Safety Officer, Bristol Myers Squibb) and Aysha Amman (Senior Director, Patient Safety & Pharmacovigilance, Amneal Pharmaceuticals), alongside safety leaders from Pfizer, Amgen and other organisations. Companies attending include Pfizer, Sanofi, Bristol Myers Squibb, Janssen and Johnson & Johnson.
The programme is where C-suite, R&D and data leaders converge to define the future of patient safety. In addition to core areas like benefit-risk management and patient-centric approaches, the congress explores how innovative technologies are transforming safety monitoring across pharmaceutical drugs, animal health, over-the-counter products, cosmetics and dietary supplements. Next-generation safety solutions leveraging AI are a central focus.
Pre-congress workshops include 'Inspection Readiness in Action: A Hands-On Workshop for Industry Teams' (covering inspection trends, building an inspection-ready organisation, mock inspection role-play, handling findings and 483s, and continuous readiness) and interactive learning sessions led by global pharmacovigilance and quality risk management experts.
Expo floor access is free with registration; fees apply for conference delegate passes. The event is B2B and not open to the general public. After more than 15 years as the definitive meeting place for the global pharmacovigilance community, the rebrand to World Patient Safety Congress reflects a mission to integrate regulatory compliance with breakthrough technology across the entire human and animal health spectrum.
